Skip to main content

Table 3 Summary of AI-based prognostic algorithms in breast cancer pathology

From: Artificial intelligence’s impact on breast cancer pathology: a literature review

Year of publication

Reference

Number of slides for training / validation

Pathologists review (training/validation)

Algorithm details

Algorithm endpoints/outputs

Algorithm performance

2020

Pantanowitz et al [24]

320 breast invasive ductal carcinoma cases, 16,800 digital image patches from 120 WSIs/140 digital image

Ten expert pathologists and 24 readers of varying expertise

RCNN by ResNet-101

Mitotic figures counting

Accuracy with AI = 55.2% compared to manually 43.9%

2020

Chow et al [25]

93 cases of phyllodes tumor

N/A

Image Management System viewer

Phyllodes tumor mitoses counting

correlation = .794; R2 = 0.63; P < .001; 95% CI, 0.270–0.373

2021

Balkenhol et al [26]

94 TNBC specimens

two histopathologists

convolutional neural networks (CNN)

TILs assessment and prognostic values

Relapse free survival HR ranging between 0.777 (CD8, IM2) and 0.915 (CD3, ITS); overall survival HR varying between 0.722 (FOXP3, ITT) and 0.908 (CD3, ITA)

2022

Wang et al [6]

Training:1567Test:1262

Pathologists

deep CNN model

Categorization of NHG2 breast tumors and its risk of recurrence

increased risk for recurrence in DG2-high (HR 1.91, 95% CI 1.11–3.29, P = 0.019)

2022

Mantrala et al [27]

Training: 46 Test: 91

Six pathologists

Unet, DenseNet backbone, preloaded ImageNet for TF, HoVerNet, pretrained ImageNet ResNet50-Preact for NP, LinkNet with EfficientNet B4 backbone for MC

Breast cancer grading

Tubular formation (κ = 0.471 each)

Nuclear pleomorphism (κ = 0.342) and was worst for mitotic count (κ = 0.233)